Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 2,084.00
+3.80 (0.18%)
Jun 27, 2025, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 158.45 billion as of June 27, 2025. Its market cap has increased by 52.75% in one year.
Market Cap
158.45B
Enterprise Value
150.58B
Revenue
19.37B
Ranking
n/a
PE Ratio
29.55
Stock Price
2,084.00
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 158.45B, an increase of 2,829,940.75%. That is a compound annual growth rate of 55.13%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,006.41B |
| Divi's Laboratories | 1,756.34B |
| Cipla | 1,222.71B |
| Apollo Hospitals Enterprise | 1,050.85B |
| Zydus Lifesciences | 988.07B |
| Mankind Pharma | 950.72B |
| Aurobindo Pharma | 651.08B |
| Fortis Healthcare | 596.95B |